Hadas Cohen-Dvashi, Ph.D.
Affiliations: | 2011 | Weizmann Institute of Science, Rehovot, Israel |
Area:
Cell Biology, Oncology, Neuroscience BiologyGoogle:
"Hadas Cohen-Dvashi"Parents
Sign in to add mentor| Yosef Yarden | grad student | 2011 | Weizmann Institute | |
| (The involvement of Neuron Navigator 3 (NAV3) in EGF-induced cell migration and in cancer.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Kreer C, Zehner M, Weber T, et al. (2020) Longitudinal Isolation of Potent Near-Germline SARS-CoV-2-Neutralizing Antibodies from COVID-19 Patients. Cell |
| Cohen-Dvashi H, Amon R, Agans KN, et al. (2020) Rational design of universal immunotherapy for TfR1-tropic arenaviruses. Nature Communications. 11: 67 |
| Ehrhardt SA, Zehner M, Krähling V, et al. (2019) Polyclonal and convergent antibody response to Ebola virus vaccine rVSV-ZEBOV. Nature Medicine |
| Cohen-Dvashi H, Kilimnik I, Diskin R. (2018) Structural basis for receptor recognition by Lujo virus. Nature Microbiology |
| Israeli H, Cohen-Dvashi H, Shulman A, et al. (2017) Mapping of the Lassa virus LAMP1 binding site reveals unique determinants not shared by other old world arenaviruses. Plos Pathogens. 13: e1006337 |
| Cohen-Dvashi H, Israeli H, Shani O, et al. (2016) The role of LAMP1 binding and pH sensing by the spike complex of Lassa virus. Journal of Virology |
| Cohen-Dvashi H, Cohen N, Israeli H, et al. (2015) Molecular Mechanism for LAMP1 Recognition by Lassa Virus. Journal of Virology. 89: 7584-92 |
| Kedmi M, Ben-Chetrit N, Körner C, et al. (2015) EGF induces microRNAs that target suppressors of cell migration: miR-15b targets MTSS1 in breast cancer. Science Signaling. 8: ra29 |
| Cohen-Dvashi H, Ben-Chetrit N, Russell R, et al. (2015) Navigator-3, a modulator of cell migration, may act as a suppressor of breast cancer progression. Embo Molecular Medicine. 7: 299-314 |
| Ben-Chetrit N, Chetrit D, Russell R, et al. (2015) Synaptojanin 2 is a druggable mediator of metastasis and the gene is overexpressed and amplified in breast cancer. Science Signaling. 8: ra7 |